188 related articles for article (PubMed ID: 29956793)
1. Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the LKB1/AMPK signaling pathway.
Kou B; Kou Q; Ma B; Zhang J; Sun B; Yang Y; Li J; Zhou J; Liu W
Oncol Rep; 2018 Sep; 40(3):1443-1450. PubMed ID: 29956793
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK/mTOR signaling pathway.
Zhang Y; Fan Y; Huang S; Wang G; Han R; Lei F; Luo A; Jing X; Zhao L; Gu S; Zhao X
Cancer Sci; 2018 Dec; 109(12):3865-3873. PubMed ID: 30259603
[TBL] [Abstract][Full Text] [Related]
3. Oridonin inhibited epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating LKB1/AMPK signaling.
Kou B; Shi Y; Zhou Z; Yun Y; Wu Q; Zhou J; Liu W
Int J Med Sci; 2024; 21(4):623-632. PubMed ID: 38464825
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone alleviates thioacetamide-induced hepatic fibrosis and inflammation by activating LKB1-AMPK signaling pathway in mice.
Bai T; Yang Y; Wu YL; Jiang S; Lee JJ; Lian LH; Nan JX
Int Immunopharmacol; 2014 Apr; 19(2):351-7. PubMed ID: 24560906
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of SIRT1-AMPK by thymoquinone in hepatic stellate cells ameliorates liver injury.
Yang Y; Bai T; Yao YL; Zhang DQ; Wu YL; Lian LH; Nan JX
Toxicol Lett; 2016 Nov; 262():80-91. PubMed ID: 27688165
[TBL] [Abstract][Full Text] [Related]
6. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
7. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
Hao P; Kang B; Li Y; Hao W; Ma F
Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
[TBL] [Abstract][Full Text] [Related]
8. Thymoquinone Inhibits Angiotensin II-Induced Proliferation and Migration of Vascular Smooth Muscle Cells Through the AMPK/PPARγ/PGC-1α Pathway.
Pei X; Li X; Chen H; Han Y; Fan Y
DNA Cell Biol; 2016 Aug; 35(8):426-33. PubMed ID: 27064837
[TBL] [Abstract][Full Text] [Related]
9. Parthenolide inhibits the tumor characteristics of renal cell carcinoma.
Liu D; Han Y; Liu L; Ren X; Zhang H; Fan S; Qin T; Li L
Int J Oncol; 2021 Jan; 58(1):100-110. PubMed ID: 33367934
[TBL] [Abstract][Full Text] [Related]
10. Thymoquinone Attenuates Acetaminophen Overdose-Induced Acute Liver Injury and Inflammation Via Regulation of JNK and AMPK Signaling Pathway.
Cui BW; Bai T; Yang Y; Zhang Y; Jiang M; Yang HX; Wu M; Liu J; Qiao CY; Zhan ZY; Wu YL; Kang DZ; Lian LH; Nan JX
Am J Chin Med; 2019; 47(3):577-594. PubMed ID: 30974967
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone inhibits metastasis of renal cell carcinoma cell 786-O-SI3 associating with downregulation of MMP-2 and u-PA and suppression of PI3K/Src signaling.
Liou YF; Hsieh YS; Hung TW; Chen PN; Chang YZ; Kao SH; Lin SW; Chang HR
Int J Med Sci; 2019; 16(5):686-695. PubMed ID: 31217736
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone induces apoptosis of human renal carcinoma Caki-1 cells by inhibiting JAK2/STAT3 through pro-oxidant effect.
Chae IG; Song NY; Kim DH; Lee MY; Park JM; Chun KS
Food Chem Toxicol; 2020 May; 139():111253. PubMed ID: 32165235
[TBL] [Abstract][Full Text] [Related]
13. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
[TBL] [Abstract][Full Text] [Related]
14. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836
[TBL] [Abstract][Full Text] [Related]
15. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
16. β-Ionone represses renal cell carcinoma progression through activating LKB1/AMPK-triggered autophagy.
Hou T; Wang Y; Dan W; Wei Y; Liu B; Que T; Lei Y; Yu B; Zeng J; Fan Y; Li L
J Biochem Mol Toxicol; 2023 Jun; 37(6):e23331. PubMed ID: 36843289
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
[TBL] [Abstract][Full Text] [Related]
18. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
Kou B; Liu W; Tang X; Kou Q
Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
[TBL] [Abstract][Full Text] [Related]
19. Silibinin inhibits epithelial‑mesenchymal transition of renal cell carcinoma through autophagy‑dependent Wnt/β‑catenin signaling.
Fan Y; Hou T; Dan W; Liu T; Luan J; Liu B; Li L; Zeng J
Int J Mol Med; 2020 May; 45(5):1341-1350. PubMed ID: 32323735
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression.
Mao S; Lu G; Lan X; Yuan C; Jiang W; Chen Y; Jin X; Xia Q
Mol Med Rep; 2017 Nov; 16(5):6190-6199. PubMed ID: 28901475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]